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Heart transplantation remains an important therapy for patients with end-stage heart failure. Approximately, 
5800 transplants are performed worldwide each year.1 The 
International Society for Heart and Lung Transplantation 
(ISHLT) registry collects data from 388 heart transplant centers 
from the United States, Europe, Australia, and New Zealand 
(covering approximately 66% of heart transplants performed 
worldwide) and has reported that the number of heart trans-
plants has decreased by 25% since the mid-1990s.1 A similar 
trend is seen in the Eurotransplant area, comprising Austria, 
Belgium, Croatia, Germany, Slovenia, and the Netherlands, 
where average annual volume has fallen from 752 heart trans-
plants between 1991 and 1995 to 573 heart transplants between 
2006 and 2010.2 In the United Kingdom, average annual vol-
ume has fallen from 196 heart transplants between 1996 and 
2002 to a nadir of 86 heart transplants in 2009 and 2010.3
There is a concern that centers may not be performing a 
sufficient number of heart transplants to maintain adequate 
skill and experience in the procedure. The relationship 
between center volume and outcome after surgical procedures 
is well established.4 Compared with low-volume centers, 
high-volume centers report lower mortality for coronary 
artery bypass grafting,5 surgery for pediatric congenital heart 
disease,6 and renal and liver transplantation.7 Concerns that the 
same principle applies to cardiac transplantation have led to 
pressure to reorganize cardiac transplantation services around 
regional or national centers.8–10 The effect of reorganization is 
uncertain, but the availability of heart transplantation could 
decrease if referral rates or donor organ use fall as a result of 
more distant transplant centers.
Within the ISHLT registry, low-volume centers perform-
ing <10 transplants per year account for 40% of centers, but 
only perform 13% of all transplants. Centers that perform 
10 to 19 transplants per year account for 39% of centers and 
perform 33% of transplants. High-volume centers performing 
>20 transplants per year account for only 21% of centers, but 
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and adjusted mortality up to 1 year and a stronger association at 5 years. When centers were grouped in volume categories, 
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high-volume centers had the lowest adjusted mortality but were not significantly better than intermediate-volume centers. 
Category limits were arbitrary and varied between studies.
Conclusions—There is a relationship between center volume and mortality in heart transplantation. The existence of a 
minimum acceptable center volume or threshold is unproven. However, a level of 10 to 12 heart transplants per year 
corresponds to the upper limit of low-volume categories that may have relatively higher mortality. It is not known whether 
outcomes for patients treated in low-volume transplant centers would be improved by reorganizing centers to ensure 
volumes in excess of 10 to 12 heart transplants per year. (Circ Cardiovasc Qual Outcomes. 2012;5:783-790.)
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perform 54% of all transplants.1 Those who call for closure of 
low-volume transplant centers cite historical registry data that 
suggest inferior outcomes at low-volume centers. Whether 
such calls are justified is unclear. Therefore, we conducted a 
systematic review to define the relationship between center 
volume and outcome after heart transplantation. We sought to 
address 2 key issues. Are low-volume centers associated with 
worse outcome in heart transplantation? Is there a volume 
threshold below which outcomes are worse?
Methods
The systematic review was performed according to current guide-
lines.11 Studies were eligible for inclusion if they described the 
association between center volume and outcome after heart transplan-
tation. No date or language limitation was imposed. Reports of pedi-
atric cardiac transplantation alone, from single centers or conference 
abstracts, were excluded. We searched Ovid MEDLINE (1948 to 
November, week 3, 2011), Embase (1980 to 2011, week 47), and the 
Cochrane library up to December 3, 2011. The following terms were 
used to search the databases: heart transplantation, cardiac transplan-
tation, heart transplant, cardiac transplant, volume, center volume, 
hospital volume, surgeon volume, workload, experience, procedure 
volume, procedural volume, outcome, treatment outcome, survival, 
mortality, morbidity, surgical complications, and postoperative com-
plications. In addition, reference lists of all identified publications 
were manually searched for further studies and websites of organiza-
tions responsible for heart transplantation searched.
Two authors (S.P. and P.J.) screened articles by title and abstract. 
The full text of potentially relevant articles was evaluated. Articles 
were included if the subject was cardiac transplantation, if center 
volume was an independent variable, and if the outcome or the as-
sociation between volume and outcome was described. Discrepancies 
regarding inclusion or exclusion of articles were resolved by discus-
sion. One author (S.P.) extracted and tabulated data from all included 
articles. Two authors (P.J. and N.H.) checked the accuracy of extract-
ed data. The following data were extracted: source of data, number 
of patients, number of centers, center volume (described as a continu-
ous or categorical variable), limits of volume categories, outcomes 
and additional analyses performed to adjust for case mix. Outcome 
data unadjusted for case mix were summarized as percent mortality 
at specified time points after cardiac transplantation. Outcome data 
adjusted for case mix were summarized using different measures 
in each study, including odds ratios, hazard ratios, stratum-specific 
likelihood ratios, and observed-to-expected mortality ratios. Study 
results were not combined on the basis of statistical and clinical judg-
ment.12,13 A combination of different outcome measures reported and 
different methods of adjustment in multivariable models meant that 
meta-analysis was likely to be biased even if alternative methods of 
meta-analysis were used.14 Forest plots were not produced for this 
reason and data are summarized in tables.
Results
Study Selection
Of 2715 articles screened, 10 studies assessed the relation-
ship between center volume and clinical outcome after car-
diac transplantation (Figure 1). The characteristics of each 
study are described in Table 1.1,15–24 One study conducted in 
the United States before 1987 used data from US centers in 
the ISHLT registry, combined with data obtained directly from 
transplant centers.15 Two studies used data from the ISHLT 
registry.1,16 Four studies used data from the United Network 
for Organ Sharing (UNOS) registry.17–20 One study used data 
from the Eurotransplant registry.21 Two studies used Italian and 
Brazilian national registry data, respectively.22,23 The number 
of centers included in each study ranged from 16 to 265 and 
number of patients from 798 to 14 401. Six studies included 
only adult patients,1,18–21,23 and 4 studies included both pedi-
atric and adult patients.15–17,22 Study populations overlapped 
between registries and over time; these interrelationships are 
shown in Figure 2.
Outcome Measures and Analysis
The primary outcome measure in all studies was all-cause 
mortality among individuals who underwent heart transplan-
tation, measured at intervals from 30 days to 5 years. The most 
frequent outcome measure was 1-year mortality. One study 
assessed the composite outcome of all-cause mortality or need 
for repeat transplantation.20 Six studies presented unadjusted 
(observed) mortality,16–19,22,23 which ranged from 12.6%19 to 
34.1%.22 All studies also presented mortality adjusted for 
baseline characteristics, with the exception of a single Ital-
ian study.22 Eight studies defined center volume as the mean 
number of transplants performed per year during the period 
of study, and it ranged from 1 year to 7 years.15–21,23 One study 
defined center volume as the mean number of heart transplants 
performed per year during the whole transplant program.22 
One study did not define center volume.1 Six studies exam-
ined center volume as a continuous variable.1,15,17,19,21,23 Six 
studies analyzed center volume by categories.16–20,22 Volume 
categories were defined using different methods: percentiles 
(n=2),18,22 threshold analysis to define statistically distinct cat-
egories (n=1),20 or by unspecified methods (n=3).16,17,19 Two 
studies provided limited data about surgeon volume; observed 
mortality did not differ with previous surgical experience.15,16
Assessment of Bias
Overlap between study data sets is a major source of bias 
(Figure 2). Three UNOS registry studies overlapped in 
time.18–20 One ISHLT registry study shared data with 3 UNOS 
WHAT IS KNOWN
•	 Registry studies have demonstrated an association 
between center volume and outcome after cardiac 
transplantation.
•	 The number of cardiac transplants performed world-
wide is static and low-volume heart transplant centers 
are common.
WHAT THE STUDY ADDS
•	 There is a consistent association between center vol-
ume and posttransplant mortality across national and 
international registry studies.
•	 However, this association is less strong than other 
important variables such as ischemic time, donor age, 
or preoperative recipient clinical status.
•	 The existence of a minimum acceptable center vol-
ume is unproven, but analysis by volume category 
suggests that centers performing under 10 to 12 heart 
transplants per year may have higher mortality than 
centers performing >12 transplants per year.
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Figure 1. Study selection. 
Table 1. Characteristics of the 10 Studies That Have Assessed the Relationship Between Center Volume and Clinical Outcome 
After Cardiac Transplantation
Study Source Year Centers Patients Outcomes
Continuous 
Data
Categorical 
Data Additional Analysis
Laffel et al15 US, ISHLT 1984–1986 56 1123 all 
ages
90-d mortality Yes No First 10 cases per unit excluded to avoid learning curve
Evans et al16 ISHLT 1988 106 1602 all 
ages
1-y survival No Yes Multivariable analysis using a piecewise exponential 
hazards modeling approach
Stehlik  
et al1,24
ISHLT 2000–2009 265 10 271,* 
10 785,† 
>18 y
1-y mortality, 5-y 
mortality
Yes No Multivariable analysis using proportional hazards model. 
Continuous factors were fit using a restricted cubic 
spline.
Hosenpud 
et al17
US, UNOS 1987–1991 150 7893 all 
ages
1-mo mortality, 1-y 
mortality
Yes Yes Mortality data adjusted for baseline characteristics 
using generalized additive model and 4 covariables
Shuhaiber 
et al18
US, UNOS 1999–2005 147 13 230 
>18 y
1-y mortality No Yes Multivariable analysis using Cox proportional hazards 
modeling
Weiss et al19 US, UNOS 1999–2006 143 14 401 
>18 y
30-d mortality, 
1-y mortality, 5-y 
mortality‡
Yes Yes Multivariable analysis using Cox proportional hazards 
regression model with factors found to be significant on 
univariable analysis
Russo et al20 US, UNOS 2001–2006 143 8029  
>18 y
1-y mortality 
or repeat 
transplantation
No Yes Multivariable logistic regression analysis
Bocchi et al22 Brazil 1984–1999 16 798 all 
ages
1-y mortality No Yes None
Smits et al21 Europe, ET 1997–1998 45 1401 
>16 y
1-y survival Yes No Multivariable modeling of expected mortality rates by 
Cox proportional hazards regression analysis, followed 
by 2 models of case-mix adjusted center volume effect
Taioli et al23 Italy 2000–2002 16 843 adult§ 1-y organ survival Yes No Multivariable modeling of expected mortality rates by 
Cox proportional hazards regression analysis
ISHLT indicates International Society for Heart and Lung Transplantation; UNOS, United Network for Organ Sharing; ET, Eurotransplant.
Details of the additional analysis are listed in Appendix in the online-only Data Supplement. 
*Patients included in 1-y analysis. 
†Patients included in 5-y analysis.
‡Five-year mortality conditional on survival at 1 year.
§Age unspecified.
 by guest on June 29, 2017
http://circoutcom
es.ahajournals.org/
D
ow
nloaded from
 
786  Circ Cardiovasc Qual Outcomes  November 2012
and 1 Italian national registry studies.1,18–20,23 Another ISHLT 
registry study shared data with 1 UNOS and 1 Brazilian 
national registry study.16,17,22 As such, an unknown number 
of patients contributed data to multiple studies, introducing 
bias that is difficult to quantify or control. Selection and 
reporting bias within registries should be minimized by the 
mandatory requirement to register and report outcomes 
for every consecutive heart transplant, although it remains 
possible that loss to follow-up could create bias. Missing data 
were unusual in the UNOS registry, which had 90% to 99% 
data entry for the majority of variables.20 Finally, high-volume 
centers tended to perform heart transplants in patients with a 
higher preoperative risk profile. Each multivariable analysis 
used different baseline characteristics and this may introduce 
performance bias if there was variation in adjustment for 
preoperative risk profile between centers (see Appendix in the 
online-only Data Supplement).
Center Volume as a Continuous  
Variable (Unadjusted)
Four studies, using data from ISHLT, UNOS, and 
Eurotransplant, examined the relationship between center 
volume as a continuous variable and observed mortality 
(Table 1).15,17,19,21 None identified a linear association between 
center volume and observed mortality. Only 1 study provided a 
statistical test; the Pearson correlation coefficient was −0.03.15 
All 4 studies plotted center volume against observed mortality; 
charts from the most recent UNOS and Eurotransplant studies 
are reproduced in Figure 3. As would be expected as a result of 
sampling variability and the play of chance, there was greater 
mortality variation in lower-volume centers.
Center Volume as a Continuous Variable (Adjusted)
Four studies examined the relationship between center 
volume as a continuous variable and mortality adjusted for 
baseline characteristics.1,19,21,23 In a report from Italy, a Cox 
proportional hazards model was used to generate adjusted 
risk of death for each center and there was no correlation 
with center volume (Pearson correlation coefficient, −0.38; 
P=0.17).23 A similar study of Eurotransplant data generated 
expected mortality rates for each center using a Cox 
proportional hazards model.21 There was a weak association 
between center volume and adjusted hazard of death 
(regression coefficient, −0.0082; P=0.02). In a multivariable 
analysis of UNOS data, lower center volume was associated 
with increased 30-day mortality; for every 1 case fewer per 
year from the median center volume, the odds of death at 
30 days increased (odds ratio, 1.02; 95% confidence interval 
[CI], 1.01–1.03; P<0.001).19 The most recent analysis of the 
ISHLT registry is shown in Figure 4; there was a significant 
relationship between center volume, modeled as a restricted 
cubic spline, and mortality at 1 year (P=0.0378) and a 
stronger relationship at 5 years (P<0.0001).1,24
Center Volume as a Categorical  
Variable (Unadjusted)
Four studies examined the relationship between center volume 
as a categorical variable and observed mortality. Data from the 
ISHLT registry in 1988 showed no significant difference in 
observed mortality by center volume category.16 A study of 16 
Brazilian transplant centers reported no significant difference 
in observed mortality by center volume category.22 Two larger 
US studies using the UNOS registry demonstrated lower 
observed mortality in high-volume centers.17,19 In the most 
recent of these studies (covering the period 1999 to 2006), 
observed 1-year mortality was 16.2% in centers performing 
<10 transplants per year compared with 12.2% in centers 
performing ≥10 transplants per year. This survival difference 
remained significant at 5 years by Kaplan-Meier analysis (log 
rank, P<0.001).19
Center Volume as a Categorical Variable (Adjusted)
One study using ISHLT data from 1988 examined the rela-
tionship between center volume as a categorical variable and 
mortality in a multivariable analysis.16 However, the volume 
categories did not include all centers, statistical methods were 
not described, and no CIs were presented.16 Four further stud-
ies, all from the UNOS registry and with overlapping time 
periods, examined the relationship between center volume 
as a categorical variable and mortality adjusted for baseline 
characteristics (Table 2).17–20 Direct comparison between stud-
ies is hindered by heterogeneous statistical adjustment for 
baseline characteristics. However, several observations can 
be made. Every study demonstrated an association between 
higher center volume and lower mortality. Mortality was sig-
nificantly higher in the lowest volume centers compared with 
 intermediate- and high-volume centers. However, differences 
in mortality between intermediate- and high-volume centers 
were not significant.
Is There a Threshold in the Volume–Outcome 
Relationship?
Only 1 study has examined multiple center volume thresholds in 
a single data set.19 In a multivariable logistic regression analysis 
of 30-day mortality, an excess risk of death was seen at center 
Figure 2. Study interrelationship. Inter-
relationship among 10 studies included. 
Partially or completely overlapping boxes 
indicate, respectively, a partial or com-
plete overlap in the registry from which 
the study population was obtained. Each 
study is numbered as referenced.
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volumes of <10 transplants per year (hazard ratio, 2.02; 95% 
CI, 1.46–2.80), <5 transplants per year (hazard ratio, 1.86; 95% 
CI, 1.04–3.32), and ≤2 transplants per year (hazard ratio, 2.15; 
95% CI, 1.02–4.56). Sequential multivariable logistic regres-
sion at all center volumes was conducted. Center volume was 
a poor predictor of 30-day mortality at all volume thresholds, 
with an area under the receiver operating curve of 0.64 to 0.665. 
No threshold of center volume reliably predicted mortality 
with greater accuracy.19 No data exist to support a threshold in 
what appears to be a continuous relationship between volume 
and outcome. Any thresholds suggested by categorical volume 
analysis are arbitrary.
Discussion
We identified 10 studies that describe the association 
between center volume and clinical outcome after cardiac 
transplantation in adults. There was no association between 
the continuous variable of center volume and crude mortality. 
There was a weak association between the continuous variable 
of center volume and adjusted mortality at 30 days and 1 year, 
but a clearer association with mortality was seen at 5 years. 
When centers were grouped in volume categories, there was 
a clear and consistent association between center volume 
and mortality. Low-volume centers had the worst outcomes. 
Intermediate-volume centers had better outcomes than low-
volume centers. High-volume centers had the best outcomes 
but were not significantly better than intermediate volume 
centers.
Statistical Limitations
Sampling variation is a major problem when assessing out-
comes after heart transplantation, both during routine center 
surveillance and in studies of center volume–outcome rela-
tionship. It is inevitable that low-volume centers will exhibit 
greater variation in mortality than high-volume centers within 
a fixed time period, simply because of the play of chance. It is 
Figure 3. Center volume vs crude mortality. A, Patient survival at 1 year posttransplant (with 95% confidence intervals), ordered by cen-
ter volume over the 2-year study period in the Eurotransplant registry.21 B, Patient mortality at 30 days posttransplant vs center volume in 
the United Network for Organ Sharing registry.19 Reproduced with permission of Wolters Kluwer Health and Elsevier Inc, respectively.
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challenging to separate true between-center differences from 
random sampling variation.21 The association between mortal-
ity and volume as a continuous variable may be concealed by 
high variation in mortality in low-volume centers. This varia-
tion is clearly seen in scatterplots of center volume versus 
observed mortality (Figure 3). These scatterplots also suggest 
a threshold effect, rather than a linear or exponential associa-
tion, arguably justifying analysis by volume category. Finally, 
statistical techniques such as multivariable analysis may over-
state the importance of variables such as center volume. In the 
most recent ISHLT analysis, the relationship between center 
volume and mortality was less strong than for every other sig-
nificant risk factor for mortality at 1 year and the majority of 
risk factors at 5 years.1,24 In the most detailed UNOS analysis, 
center volume was estimated to account for <1% of total mor-
tality variance after cardiac transplantation.19
The evidence has many limitations, the foremost being 
reliance on UNOS registry reports that overlap in time. Only 
3 studies contained solely non-US data.21–23 Little is known 
about the volume–outcome relationship in much of Europe, 
Asia, or Australia. Population density, donor organ availabil-
ity, and transport systems are important for transplantation 
and may influence the volume–outcome relationship. A fur-
ther limitation is that all studies had mortality as the sole out-
come measure and only 2 studies assessed outcomes beyond 
1 year.1,19 No studies addressed pretransplant outcomes (wait-
ing list mortality) or long-term posttransplant outcomes such 
as quality of life, graft rejection, or vasculopathy and need 
for further interventions such as renal replacement therapy or 
repeat transplantation. Finally, much of the published regis-
try data are old. Five studies used 20th century data, before 
advances in antibody detection, immunosuppression, and 
short-term mechanical circulatory support after transplan-
tation.15–17,21,22 However, it is noteworthy that the volume– 
outcome relationship appears to be relatively consistent in 
studies spanning 3 decades of transplantation.
Can Low-Volume Transplant Centers  
Have Satisfactory Outcomes?
Two studies described the performance of individual, small 
centers. Using an empirical Bayes estimate of center effects, 
18 of 20 centers in the Eurotransplant registry with an annual 
Table 2. Clinical Outcomes With Adjustment for Baseline Characteristics Subdivided by Volume Category
Study Measurement Outcome Measure
Volume Category 1 
(Lowest) Volume Category 2 Volume Category 3
Volume Category  
4 (Highest) P
Hosenpud  
et al17
Probability of death for typical 
patient*
1-y mortality <9 CTX/y
21%
>9 CTX/y
17%
<0.001
Shuheiber 
et al20
Multivariable analysis hazard 
ratio (95% CI)
1-y mortality 0-11 CTX/y
reference
12-21 CTX/y
0.71 (0.62-0.82)
22–33 CTX/y 
0.64 (0.56–0.74)
≥34 CTX/y 
0.56 (0.48–0.65)
Weiss et al18 Multivariable analysis odds  
ratio (95% CI)
30d mortality ≤2 CTX/y
2.15 (1.02-4.56)
<5 CTX/y
1.86 (1.04-3.32)
<10 CTX/y
2.02 (1.46-2.80)
<40 CTX/y
reference
>2 CTX/y
reference
>5 CTX/y
reference
>10 CTX/y
reference
≥40 CTX/y
0.35 (0.22-0.56)
Russo et al19 Stratum-specific likelihood  
ratio (95% CI)
1-y mortality or repeat 
transplantation
<10.5 CTX/y
1.37 (1.23-1.53)
10.5-47 CTX/y
0.96 (0.91-1.0)
>47 CTX/y 
0.84 (0.74–0.95)
CTX indicates cardiac transplant; CI, confidence interval. 
*Typical patient defined as hospitalized patient with noncongenital heart disease undergoing first transplantation performed at the midpoint of the study duration.
Figure 4. Center volume vs adjusted mortality in the International 
Society for Heart and Lung Transplantation registry. Relative risk of 
mortality by center volume at 1 year (Upper) and 5 years (Lower) 
after heart transplantation in the 2011 report from the  International 
Society for Heart and Lung Transplantation registry.1 The dotted 
lines represent upper and lower 95% confidence intervals. One-
year mortality is compared with the median center volume of 22 
cases per year. Five-year mortality is compared with the median 
center volume of 23 cases per year.
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volume of <10 transplants per year had mortality rates in 
keeping with their case mix.21 In contrast, only 2 of 4 centers 
in the Italian national registry with an annual volume of 
<10 transplants per year had mortality rates in keeping with 
their case mix.23 Low-volume transplant centers may have 
satisfactory outcomes but require surveillance. Because low-
volume centers are expected to have a large variation in annual 
mortality rates, simply through sampling variation, statistical 
process control techniques such as cumulative sum charts are 
required to monitor performance.25,26 There are no international 
guidelines regarding acceptable volumes for heart transplant 
centers. In the United States, Centers for Medicare and Medicaid 
Services require heart transplant centers to perform at least 10 
transplants per year and centers are defined as functionally 
inactive if no transplants are performed for 3 months.27
Should Transplant Centers Be Reorganized to 
Ensure That All Have Acceptable Annual Volume?
It has been argued that outcomes could be improved if low-
volume centers were closed and patients traveled to high- 
volume centers.8,9 Higher-volume centers may achieve abso-
lute risks for unadjusted mortality of up to 4% lower.19 Smaller 
reductions in absolute risk have justified the reorganization of 
reperfusion therapy in acute ST-segment elevation myocar-
dial infarction. In the only study to address the issue, patient 
home-to-transplant center distances of >300 miles did not 
reduce survival or increase complications after cardiac trans-
plantation in the United States.28 These arguments may be 
flawed. First, the incremental mortality reduction associated 
with transplantation in a higher-volume center may not be 
clinically meaningful. For example, closure of a low-volume 
center with a mortality rate of 16% would save 1 life every 2.5 
years if all patients were transplanted at a high-volume center 
with a mortality rate of 12%.19 Second, closure of low-volume 
transplant centers has never been demonstrated to improve 
outcomes. There may be unexpected adverse effects, such as 
reduced rates of referral for transplantation, increased waiting 
list mortality, a reduced pool of organs available for transplan-
tation, or prolonged ischemic times resulting in worse out-
comes for patients with advanced heart failure.
Conclusions
There is undoubtedly a relationship between the volume of 
heart transplants performed and mortality. The existence of 
an optimal or minimum acceptable center volume is uncer-
tain. However, an annual volume of 10 to 12 transplants cor-
responds with the upper limit of low-volume categories that 
may have relatively higher mortality. It is unclear whether 
outcomes for patients treated in low-volume transplant cen-
ters would be improved by reorganizing centers to ensure vol-
umes in excess of 10 to 12 heart transplants per year. Closing 
transplant centers may have adverse consequences on other 
factors, such as ischemic time, that are associated with worse 
outcome. These issues should be explored before transplant 
services are reorganized.
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Appendix 
Hosenpud 1994.  Covariates in analysis: first versus repeat transplantation, medical condition at 
time of transplantation (home, hospital, ITU), congenital heart disease, date of transplantation. 
Shuheiber 2010.  Donor variables analyzed include age, gender, and cold ischemia time. Recipient 
variables analyzed include age, gender, race, body mass index, diagnoses (including primary reason 
for transplantation, presence of hypertension, diabetes, need for renal replacement therapy, or 
mechanical ventilation), creatinine, bilirubin, cardiac output, and presence or absence of a left 
ventricular assist device. 
Weiss 2008.  Variables in multivariable analysis for mortality: mean annual center orthotopic heart 
transplant (OHT) volume (continuous), age, sex, history of hypertension, history of diabetes 
mellitus, preoperative creatinine, panel reactive antibody level, UNOS status 1, donor age, human 
leukocyte antigen mismatch, ischemic time, preoperative cardiac index, preoperative pulmonary 
vascular resistance, bicaval anastamotic technique, need for mechanical ventilation before 
undergoing transplantation, and transplantation year. 
Russo 2010.  Variables in multivariate analysis for one year mortality or retransplantation: recipient 
age (40 years, 40 to 54 years, 55 to 69 years, 70 years); recipient heart failure aetiology (congenital, 
hypertrophic, ischemic, restrictive, sarcoidosis, valvular, other); recipient previous heart transplant 
within 90 days; recipient pulmonary vascular resistance (PVR) >4 Wood units; recipient estimated 
glomerular filtration rate (<33 mL/min, 33-53 mL/min, >53 mL/min); recipient total bilirubin >2.0 
mg/dL; recipient diabetes mellitus; recipient peripheral vascular disease; recipient receiving steroids 
at transplant; recipient need for ventilator; recipient hypertension; recipient extracorporeal 
membrane oxygenation (ECMO) at transplant; recipient extracorporeal left ventricular assist 
device–only at transplant; recipient intracorporeal left ventricular assist device– only at transplant; 
recipient right ventricular assist device–only at transplant; recipient biventricular assist device at 
transplant; recipient paracorporeal ventricular assist device at transplant; recipient total artificial 
heart at transplant; recipient intraaortic balloon pump at transplant; recipient in intensive care unit at 
transplant; recipient hospitalized at transplant; donor age (20-29 years, 30-39 years, 40-50 years and 
>50 years); donor:recipient weight ratio of 0.8; female donor to male recipient; female donor to 
female recipient; female donor to male recipient; male donor to female recipient; kidney donor 
concurrently; lung donor concurrently; pancreas donor concurrently; ischemic time (<1 hour, 1-4 
hours, and >4 hours); mean number of heart transplants per center per year; and year of transplant.	  
Smits 2003.  Variables in the Cox proportional hazards model: recipient gender, recipient age, 
disease, mechanical support at time of offer , respirator, inotropic support, serum creatinine 
(mg/dL), cold ischemic time, donor age, donor gender, cause of death (donor), local donor, 
residence at time of offer, donor:recipient weight match. 
Taioli 2005.  Variables in the Cox proportional hazards model: ischemia time, recipient age, 
recipient gender, donor age, number of previous transplants, previous pathology, combined 
transplant, vascular resistance, creatinine, bilirubin, type of transplant, previous cardiac surgery, 
weight match, hospitalization prior to transplant, coronary angiography, echocardiography. 
 
